← Back to Search

Decision Coaching for Lung Cancer Screening

N/A

Recruiting

Led By Anita Y Kinney, PhD, RN

Research Sponsored by Rutgers, The State University of New Jersey

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Participants completing the semi-structured interviews must be age 18 or older

Patients must be 50 to 77 years of age

Must not have

Providers/administrators who are unable to provide informed consent

Patients with a history of lung cancer

Timeline

Screening 3 weeks

Treatment Varies

Follow Up the change in baseline, three months and five years

Awards & highlights

Summary

This trial is testing whether navigator decision coaching, compared to enhanced usual care, results in better decision making for lung cancer screening, more screenings, and increased adherence to repeat screenings and diagnostic testing. A booster coaching session is also being tested to see if it increases adherence to repeat screenings.

Who is the study for?

The TELESCOPE trial is for English-speaking adults aged 50-77 who have a significant smoking history (at least 20 pack-years) and are either current smokers or quit within the last 15 years. They must be due for a non-emergency medical visit but not pregnant, without lung cancer history, nor screened for it in the past year. Health providers involved need to work at participating sites.

What is being tested?

This study tests if remote decision coaching with navigation intervention (TELESCOPE) improves shared decision-making in lung cancer screening compared to usual care. It aims to increase knowledge about screening, encourage more discussions, and boost adherence to repeat screenings and smoking cessation referrals.

What are the potential side effects?

Since this trial involves decision coaching rather than medication or invasive procedures, traditional side effects are not expected. However, participants may experience psychological impacts from increased awareness of their health status.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am between 50 and 77 years old.

Select...

I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am unable to understand and give informed consent.

Select...

I have a history of lung cancer.

Select...

I am currently pregnant.

Select...

I am unable to understand or sign the consent form.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ the change in baseline, three months and five years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~the change in baseline, three months and five years

This trial's timeline: 3 weeks for screening, Varies for treatment, and the change in baseline, three months and five years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

To assess shared decision making

Secondary study objectives

Tobacco treatment referral

Other study objectives

Completion of diagnostic testing

Receipt of tobacco treatment

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: TELESCOPE interventionExperimental Treatment1 Intervention

Participants will be surveyed at baseline and at one-week after the scheduled primary care office visit. If a participant is a current smoker then they are offered and navigated to evidence-based smoking cessation. If the participant is interested in screening, an LDCT is ordered. Support for screening, diagnostic testing and oncology care will be provided as needed from the Nurse Navigators.

Group II: Enhanced usual care (EUC)Active Control1 Intervention

Participants will be surveyed at baseline and at one-week after the scheduled primary care office visit. Primary and secondary outcome data related to the office visit will be collected.

0 / 7Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH

3,909 Previous Clinical Trials

47,755,898 Total Patients Enrolled

Rutgers, The State University of New JerseyLead Sponsor

442 Previous Clinical Trials

65,022 Total Patients Enrolled

National Institutes of Health (NIH)NIH

2,789 Previous Clinical Trials

8,137,724 Total Patients Enrolled

Media Library

Remote Decision Coaching with Navigation Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05491213 — N/A

Lung Cancer Research Study Groups: TELESCOPE intervention, Enhanced usual care (EUC)

Lung Cancer Clinical Trial 2023: Remote Decision Coaching with Navigation Intervention Highlights & Side Effects. Trial Name: NCT05491213 — N/A

Remote Decision Coaching with Navigation Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05491213 — N/A

~237 spots leftby Dec 2026

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.